Literature DB >> 17523271

Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.

Taizen Urahashi1, Masakazu Yamamoto, Takehito Ohtsubo, Hideo Katsuragawa, Satoshi Katagiri, Ken Takasaki.   

Abstract

BACKGROUND/AIMS: Patients with advanced intrahepatic cholangiocarcinoma (ICC) have a poor outcome even if they undergo extended radical surgery. Hepatopancreatoduodenectomy (HPD; hepatectomy with pancreatoduodenectomy) for ICCs may be expected to provide a favorable outcome if curative resection is reasonable and patients can tolerate the radical major procedure.
METHODOLOGY: Between January 1981 and March 2002, 152 hepatic resections were performed for ICC. Of these, 12 patients underwent HPD for ICC at the same institute of Gastroenterology, Tokyo Women's Medical University. HPD for ICC was indicated in patients who (1) require dissection of the peripancreatic lymph nodes, (2) exhibit direct invasion of intrapancreatic bile duct, (3) show signs of intrapancreatic bile ductal growth.
RESULTS: Characteristics of the short-term survivors (died within 12 months), compared with long-term survivors (survived more than 12 months), indicated that they were more likely to be positive intrahepatic metastasis, to be positive lymph node metastasis, to be positive portal venous invasion, and margins of resected surface with residual tumor. The actuarial overall 1-, 3-, 5-, 10-year survival rates were 42%, 33%, 33%, and 23%, respectively. The 5-year survival rate in patients without lymph node metastasis was significantly better (p = 0.045) than that of patients with lymph node metastasis. The patients who underwent potentially curative resection had significantly better 5-year survival rates than those who underwent non-curative resection. Four patients survived for at least 5 years and two of these patients survived for more than 10 years. Nine patients developed recurrence after resection, and of these, 5 patients with recurrence died within 12 months after surgery.
CONCLUSIONS: HPD is considered to be an efficacious procedure for advanced ICC and long-term survival may be possible in a selected group of patients.

Entities:  

Mesh:

Year:  2007        PMID: 17523271

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Radical surgery: vascular and pancreatic resection for cholangiocarcinoma.

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 2.  A modified surgical approach of hepatopancreatoduodenectomy for advanced gallbladder cancer: Report of two cases and literature review.

Authors:  Jian Wang; Zhan-Guo Zhang; Wan-Guang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 3.  A systematic review of safety and efficacy of hepatopancreatoduodenectomy for biliary and gallbladder cancers.

Authors:  Yanming Zhou; Zuobing Zhang; Lupeng Wu; Bin Li
Journal:  HPB (Oxford)       Date:  2015-11-30       Impact factor: 3.647

4.  Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.

Authors:  Toshio Nakagohri; Taira Kinoshita; Masaru Konishi; Shinichiro Takahashi; Naoto Gotohda
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

5.  Guidelines for palliative surgery of cholangiocarcinoma.

Authors:  H Witzigmann; H Lang; H Lauer
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 6.  Current status of intrahepatic cholangiocarcinoma.

Authors:  Jian Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.